VFC
52
8
YUM
58
6
NSC
56
3
RIG
49
5
TAP
63
2
VNO
68
8
ALL
56
-10
SHW
56
4
DAL
70
5
LUV
54
5
PM
62
4
HUM
59
3
WFC
71
3
ES
46
5
MCK
64
-2
SIG
58
3
ED
62
4
LRCX
55
3
T
62
5
PPG
60
3
VFC
52
8
YUM
58
6
NSC
56
3
RIG
49
5
TAP
63
2
VNO
68
8
ALL
56
-10
SHW
56
4
DAL
70
5
LUV
54
5
PM
62
4
HUM
59
3
WFC
71
3
ES
46
5
MCK
64
-2
SIG
58
3
ED
62
4
LRCX
55
3
T
62
5
PPG
60
3
Financhill
Back

Karuna Therapeutics 10K Form

Buy
66

KRTX
Karuna Therapeutics

Last Price:
197.50
Seasonality Move:
1.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRTX News And Ratings

See the #1 stock for the next 7 days that we like better than KRTX

KRTX Financial Statistics

Sales & Book Value

Annual Sales: $10.64M
Cash Flow: $-110.63M
Price / Cash Flow: 0
Annual Sales: $35.06
Price / Book: 5.61

Profitability

EPS (TTM): -10.93000
Net Income (TTM): $-396.07M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Karuna Therapeutics Earnings Forecast

Key Karuna Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,107.61% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRTX is -2,597.18% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Karuna Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: KRTX
CUSIP: 48576A
Website: karunatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KRTX Technical Analysis vs Fundamental Analysis

Buy
66
Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?